BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33022479
Number of visits today
6678
Number of downloads
16211927
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Marshall GP 2nd, Cserny J, Perry DJ, Yeh WI, Seay HR, Elsayed AG, Posgai AL, Brusko TM. Clinical Applications of Regulatory T cells in Adoptive Cell Therapies. Cell Gene Ther Insights 2018;4:405-29. [PMID: 34984106 DOI: 10.18609/cgti.2018.042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Marshall GP, Cserny J, Wang CW, Looney B, Posgai AL, Bacher R, Keselowsky B, Brusko TM. Biomaterials-based nanoparticles conjugated to regulatory T cells provide a modular system for localized delivery of pharmacotherapeutic agents. J Biomed Mater Res A 2023;111:185-97. [PMID: 36082558 DOI: 10.1002/jbm.a.37442] [Reference Citation Analysis]
2 Brown ME, Peters LD, Hanbali SR, Arnoletti JM, Sachs LK, Nguyen KQ, Carpenter EB, Seay HR, Fuhrman CA, Posgai AL, Shapiro MR, Brusko TM. Human CD4(+)CD25(+)CD226(-) Tregs Demonstrate Increased Purity, Lineage Stability, and Suppressive Capacity Versus CD4(+)CD25(+)CD127(lo/-) Tregs for Adoptive Cell Therapy. Front Immunol 2022;13:873560. [PMID: 35693814 DOI: 10.3389/fimmu.2022.873560] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Shapiro MR, Peters LD, Brown ME, Cabello-kindelan C, Posgai AL, Bayer AL, Brusko TM. Insulin-like Growth Factor-1 Synergizes with IL-2 to Induce Homeostatic Proliferation of Regulatory T cells.. [DOI: 10.1101/2022.05.12.491665] [Reference Citation Analysis]
4 Nambam B, Haller MJ, Winter WE, Schatz D. Autoimmune Polyglandular Syndromes. Sperling Pediatric Endocrinology 2021. [DOI: 10.1016/b978-0-323-62520-3.00022-1] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345